The treatment of patients with lupoid leishmaniasis.

Effect of topical sodium chlorite (NaClO2) on the treatment course of lupoid leishmaniasis: A clinical trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190114042356N1

Enrollment

Registered

2019-02-02

Start date

2019-02-20

Completion date

Unknown

Last updated

2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lupoid leishmaniasis. Leishmaniasis, unspecified

Interventions

Intervention group were subjected to topical sodium chlorosome (including 12 mM NaClO2 with 10-11 PH and 2.4% glycerol with brand name of Oxoferin) twice a day for 6 weeks..

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: History of a history of positive smear for leishman body or pathology Clinical features associated with lesion of lupoid leishmaniasis

Exclusion criteria

Exclusion criteria: Using alternative treatments 2 months prior or during the intervention Pregnancy or breastfeeding

Design outcomes

Primary

Measure	Time frame
Therapeutic responses. Timepoint: before and 6 weeks after the treatment. Method of measurement: The photos taken of lesion.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Mashayekhi

Mashhad University of Medical Sciences

mashayekhiv@mums.ac.ir+98 51 3606 5215

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 1, 2026